Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).
Pfizer says it will advance once-daily GLP-1 pill after all
Pfizer said Thursday that it plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, meant to be a pill version in